Mkts

Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXP
$3.01-0.23 (-7.10%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
2.903.25
52-week range
3.2120.56
Today
Open3.25
Previous close3.01
Volume—
Valuation
Market cap62.96M
P/E ratio—
EPS (TTM)-12.92
Income & risk
Dividend / yield—
Beta2.01
Avg volume698.8K
Discussion

TNXP News

Stories mentioning TNXP from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue6,8785,3903,2901,9982,4292,5822,8222,208
Cost of Goods Sold1,5781,0581,3673,272943.001,1831,5553,367
Gross Profit5,3004,3321,923(1,274)1,4861,3991,267(1,159)
Operating Expenses
Research & Development18,21316,9419,28910,8207,4368,2979,1149,698
Sales General & Admin28,62435,67725,70116,20210,10415,5827,7077,502
Total Operating Expenses
Operating Income (Loss)(41,537)(48,286)(33,067)(28,296)(16,054)(22,480)(15,554)(77,316)
Interest Income1,3461,231394.0018.00
Interest Expense
Other Expense(3.00)(578.00)(1,156)(1,955)394.00376.00(44.00)(606.00)
Pretax Income
Tax Provision
Net Income (Loss)(40,194)(46,910)(32,010)(28,272)(16,829)(22,108)(14,213)(78,776)
Earnings Per Share (Basic)(2.93)(5.51)(3.59)(3.86)(2.84)(30.04)(22.68)(1,921)
Earnings Per Share (Diluted)(2.93)(5.51)(3.59)(3.86)(2.84)(30.04)(22.68)(1,921)
Weighted Average Shares Outstanding (Basic)13,7078,5118,9237,3275,927736.00627.0041.00
Weighted Average Shares Outstanding (Diluted)13,7078,5118,9237,3275,927736.00627.0041.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TNXP

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is a stock listed on the Nasdaq Stock Market under the ticker symbol TNXP. It last traded at $3.01 (Nov 13, 2026, 4:00 PM ET), down 7.1% on the day. That gives Tonix Pharmaceuticals a market capitalisation of $63.0M.

Over the past 52 weeks TNXP has traded between $3.21 and $20.56.

Revenue for the quarter ended Mar 31, 2026 was $6.9M; a net loss of $40.2M. Revenue was up 183% from $2.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$6.9M-$40.2M-584.4%
Dec 31, 2025$5.4M-$46.9M-870.3%
Sep 30, 2025$3.3M-$32.0M-972.9%
Jun 30, 2025$2.0M-$28.3M-1415.0%

From Tonix Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…